Screening newborns for metabolic disorders based on targeted metabolomics using tandem mass spectrometry

키워드

참고문헌 (40)

1. Chace DH, "Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy from infants with unexplained cause of death", Clin Chem, 47, pp.1166~1182 (2001)
2. Chace DH, "Laboratory integration and utilization of tandem mass spectrometry in neonatal screening: a model for clinical mass spectrometry in the next millennium", Acta Paediatr Suppl, 88, pp.45~47 (1999)
3. Chace DH, "Use of phenylalanine-to-tyrosine ratio determined by tandem mass spectrometry to improve newborn screening for phenylketonuria of early discharge specimens collected in the first 24 hours", Clin Chem, 44, pp.2405~2409 (1998)
4. Chen WH, "Web-based newborn screening system for metabolic diseases: machine learning versus clinicians", J Med Internet Res, 15, pp.e98~ (2013)
5. Hall PL, "Postanalytical tools improve performance of newborn screening by tandem mass spectrometry", Genet Med, 16, pp.889~895 (2014)
6. la Marca G., "Mass spectrometry in clinical chemistry:the case of newborn screening", J Pharm Biomed Anal, 101, pp.174~182 (2014)
7. Clinical and Laboratory Standard Institute, "Newborn screening by tandem mass spectrometry; Approved guideline", Clinical and Laboratory Standard Institute, ~ (2010)
8. Miller JH 4th, "A quantitative method for acylcarnitines and amino acids using high resolution chromatography and tandem mass spectrometry in newborn screening dried blood spot analysis", J Chromatogr B Analyt Technol Biomed Life Sci, 903, pp.142~149 (2012)
9. Wang C, "Newborn screening of phenylketonuria using direct analysis in real time (DART) mass spectrometry", Anal Bioanal Chem, 405, pp.3159~3164 (2013)
10. Dott M, "Metabolic disorders detectable by tandem mass spectrometry and unexpected early childhood mortality: a population-based study", Am J Med Genet A, 140, pp.837~842 (2006)
11. Rinaldo P, "Clinical biochemical genetics in the twenty-first century", Acta Paediatr Suppl, 93, pp.22~26 (2004)
12. Walter JH, "Bloodspot acylcarnitine and amino acid analysis in cord blood samples: efficacy and reference data from a large cohort study", J Inherit Metab Dis, 32, pp.95~101 (2009)
13. Duffey TA, "A tandem mass spectrometry triplex assay for the detection of Fabry, Pompe, and mucopolysaccharidosis-I (Hurler)", Clin Chem, 56, pp.1854~1861 (2010)
14. Coman D, "Extended newborn screening:an update for the general paediatrician", J Paediatr Child Health, 48, pp.E68~E72 (2012)
15. Mak CM, "Inborn errors of metabolism and expanded newborn screening: review and update", Crit Rev Clin Lab Sci, 50, pp.142~162 (2013)
16. Levy PA., "An overview of newborn screening", J Dev Behav Pediatr, 31, pp.622~631 (2010)
17. Rebollido-Fernandez MM, "Development of electrospray ionization tandem mass spectrometry methods for the study of a high number of urine markers of inborn errors of metabolism", Rapid Commun Mass Spectrom, 26, pp.2131~2144 (2012)
18. Eddy M, "Newborn metabolic screening and related pitfalls", Mo Med, 106, pp.234~240 (2009)
19. Rashed MS, "Screening blood spots for inborn errors of metabolism by electrospray tandem mass spectrometry with a microplate batch process and a computer algorithm for automated flagging of abnormal profiles", Clin Chem, 43, pp.1129~1141 (1997)
20. Scolamiero E, "Targeted metabolomics in the expanded newborn screening for inborn errors of metabolism", Mol Biosyst, 11, pp.1525~1535 (2015)
21. Selim LA, "Selective screening for inborn errors of metabolism by tandem mass spectrometry in Egyptian children: a 5 year report", Clin Biochem, 47, pp.823~828 (2014)
22. Waisbren SE, "Neuropsychological outcomes in fatty acid oxidation disorders: 85 cases detected by newborn screening", Dev Disabil Res Rev, 17, pp.260~268 (2013)
23. Marquardt G, "Enhanced interpretation of newborn screening results without analyte cutoff values", Genet Med, 14, pp.648~655 (2012)
24. Abdenur JE, "Diagnosis of isovaleric acidaemia by tandem mass spectrometry: false positive result due to pivaloylcarnitine in a newborn screening programme", J Inherit Metab Dis, 21, pp.624~630 (1998)
25. De T, "Postnatal variations in blood free and acylcarnitines", J Clin Lab Anal, 25, pp.126~129 (2011)
26. Janzen N, "UPLC-MS", MS analysis of C5-acylcarnitines in dried blood spots, 2013, pp.421, 41~45
27. Forni S, "Rapid determination of C4-acylcarnitine and C5-acylcarnitine isomers in plasma and dried blood spots by UPLC-MS", MS as a second tier test following flow-injection MS, Mol Genet Metab, pp.2010, 101[DOI]
28. Blois B, "Newborns with C8-acylcarnitine level over the 90th centile have an increased frequency of the common MCAD 985A>G mutation", J Inherit Metab Dis, 28, pp.551~556 (2005)
29. Najdekr L, "Oxidized phosphatidylcholines suggest oxidative stress in patients with medium-chain acyl-CoA dehydrogenase deficiency", Talanta, 139, pp.62~66 (2015)
30. Aksglaede L, "Abnormal newborn screening in a healthy infant of a mother with undiagnosed mediumchain acyl-CoA dehydrogenase deficiency", JIMD Rep, 23, pp.67~70 (2015)
31. Fingerhut R, "Stability of acylcarnitines and free carnitine in dried blood samples: implications for retrospective diagnosis of inborn errors of metabolism and neonatal screening for carnitine transporter deficiency", Anal Chem, 81, pp.3571~3575 (2009)
32. Ozben T., "Expanded newborn screening and confirmatory follow-up testing for inborn errors of metabolism detected by tandem mass spectrometry", Clin Chem Lab Med, 51, pp.157~176 (2013)
33. Blau N, "Diagnosis, classification, and genetics of phenylketonuria and tetrahydrobiopterin (BH4) deficiencies", Mol Genet Metab, 104(Suppl), pp.S2~S9 (2011)
34. Janzen N, "Towards newborn screening for ornithine transcarbamylase deficiency: fast non-chromatographic orotic acid quantification from dried blood spots by tandem mass spectrometry", Clin Chim Acta, 430, pp.28~32 (2014)
35. Fingerhut R., "Recall rate and positive predictive value of MSUD screening is not influenced by hydroxyproline", Eur J Pediatr, 168, pp.599~604 (2009)
36. Sun A, "Expanded newborn screening for inborn errors of metabolism: overview and outcomes", Adv Pediatr, 59, pp.209~245 (2012)
37. Simonsen H, "Report from the 4th meeting of the International Society for Neonatal Screening. Acta Paediatr Suppl", Report from the 4th meeting of the International Society for Neonatal Screening, 88, pp.52~54 (1999)
38. Teodoro-Morrison T, "Dynamic biological changes in metabolic disease biomarkers in childhood and adolescence: a CALIPER study of healthy community children", Clin Biochem, 48, pp.828~836 (2015)
39. Oladipo OO, "Impact of premature birth and critical illness on neonatal range of plasma amino acid concentrations determined by LC-MS", MS, 2011, pp.104, 476~479
40. Turgeon CT, "Determination of total homocysteine, methylmalonic acid, and 2-methylcitric acid in dried blood spots by tandem mass spectrometry", Clin Chem, 56, pp.1686~1695 (2010)

관련 논문AI추천